pubmed-article:10836526 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0038250 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0229664 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0004561 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C1510411 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C1332710 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0205359 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C1317973 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0183683 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C0344211 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C1521721 | lld:lifeskim |
pubmed-article:10836526 | lifeskim:mentions | umls-concept:C1171411 | lld:lifeskim |
pubmed-article:10836526 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10836526 | pubmed:dateCreated | 2000-7-31 | lld:pubmed |
pubmed-article:10836526 | pubmed:abstractText | We show that bone marrow (BM) CD34+ progenitor cells from rheumatoid arthritis (RA) patients have the capacity to support spontaneous transformation of peripheral blood B cells. CD34+ cells purified from BM blood from eight RA patients and eight osteoarthritis (OA) patients were expanded with granulocyte/macrophage colony stimulating factor (GM-CSF) for 4-6 weeks. GM-CSF-stimulated BM CD34+ cells from three of eight RA patients, but none from seven OA patients, gave rise to spontaneous transformation of highly purified B cells of Epstein-Barr virus (EBV)-seronegative healthy donors. GM-CSF-stimulated BM CD34+ cells from four of six RA patients and from one of four OA patients also supported the spontaneous transformation of peripheral blood B cells from EBV-seropositive healthy donors. All the transformed B cell lines were positive for EBV-DNA as determined by PCR. Neither GM-CSF-stimulated BM CD34+ cells alone nor highly purified B cells alone gave rise to spontaneously transformed B cell lines. These results suggest that the capacity of BM CD34+ cells to support survival of B cells might contribute to the pathogenesis of RA by sustaining abnormal B cell responses. | lld:pubmed |
pubmed-article:10836526 | pubmed:language | eng | lld:pubmed |
pubmed-article:10836526 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10836526 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10836526 | pubmed:issn | 0172-8172 | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:NakamuraHH | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:TomitaTT | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:YanagidaTT | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:YoshinoSS | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:OchiTT | lld:pubmed |
pubmed-article:10836526 | pubmed:author | pubmed-author:HirohataSS | lld:pubmed |
pubmed-article:10836526 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10836526 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:10836526 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10836526 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10836526 | pubmed:pagination | 153-9 | lld:pubmed |
pubmed-article:10836526 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:meshHeading | pubmed-meshheading:10836526... | lld:pubmed |
pubmed-article:10836526 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10836526 | pubmed:articleTitle | Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals. | lld:pubmed |
pubmed-article:10836526 | pubmed:affiliation | Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan. shunsei@med.teikyo-u.ac.jp | lld:pubmed |
pubmed-article:10836526 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10836526 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10836526 | lld:pubmed |